Business in Brief: Experimental Ebola Treatment Approved for Use in Congo

Gilead Science’s experimental ebola treatment approved for use in Congo ■ Bank regulator extends benefits to encourage downsizing ■ BiondVax Pharmaceuticals CEO admits to insider trading, to pay 70,000 shekel fine

Send in e-mailSend in e-mail
A Congolese health worker administers Ebola vaccine to a boy who had contact with an Ebola sufferer in the village of Mangina in North Kivu province of the Democratic Republic of Congo, August 18, 2018.
A Congolese health worker administers Ebola vaccine to a boy who had contact with an Ebola sufferer in the village of Mangina in North Kivu province of the Democratic Republic of Congo.Credit: REUTERS/Olivia Acland/File Photo

Comments